1. Home
  2. FG vs RCUS Comparison

FG vs RCUS Comparison

Compare FG & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo F&G Annuities & Life Inc.

FG

F&G Annuities & Life Inc.

HOLD

Current Price

$24.51

Market Cap

3.2B

Sector

Finance

ML Signal

HOLD

Logo Arcus Biosciences Inc.

RCUS

Arcus Biosciences Inc.

HOLD

Current Price

$21.32

Market Cap

2.8B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FG
RCUS
Founded
1959
2015
Country
United States
United States
Employees
1338
N/A
Industry
Life Insurance
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.2B
2.8B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
FG
RCUS
Price
$24.51
$21.32
Analyst Decision
Hold
Buy
Analyst Count
1
10
Target Price
$35.00
$29.20
AVG Volume (30 Days)
578.2K
1.1M
Earning Date
05-06-2026
05-05-2026
Dividend Yield
4.12%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$247,000,000.00
Revenue This Year
$7.94
N/A
Revenue Next Year
$5.51
$70.88
P/E Ratio
$8.41
N/A
Revenue Growth
N/A
N/A
52 Week Low
$20.57
$6.79
52 Week High
$37.19
$26.40

Technical Indicators

Market Signals
Indicator
FG
RCUS
Relative Strength Index (RSI) 53.80 47.82
Support Level $20.97 $20.35
Resistance Level $29.63 $21.55
Average True Range (ATR) 0.76 1.14
MACD 0.49 -0.24
Stochastic Oscillator 92.36 25.36

Price Performance

Historical Comparison
FG
RCUS

About FG F&G Annuities & Life Inc.

F&G Annuities & Life Inc is a provider of insurance solutions serving retail annuity and life customers as well as institutional clients. Through its insurance subsidiaries, including FGL Insurance and Fidelity & Guaranty Life Insurance Company of New York it markets a broad portfolio of deferred annuities (fixed indexed annuities (FIAs) and multi-year guarantee annuities (MYGAs) or other fixed rate annuities), immediate annuities, indexed universal life (IUL) insurance, funding agreements through funding agreement-backed notes (FABN) issuances and the Federal Home Loan Bank of Atlanta (FHLB)), and pension risk transfer (PRT) solutions.

About RCUS Arcus Biosciences Inc.

Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.

Share on Social Networks: